Â鶹ֱ²¥app

Update your Knowledge with MKSAP Q&A

MKSAP 19

For over 50 years, the Medical Knowledge Self-Assessment Program (MKSAP) has been the most trusted resource in self-assessment and continuous learning for internal medicine physicians and residents. The tradition continues with the upcoming ACP MKSAP.

ACP MKSAP, launching February 3, 2025, is the all-new, all digital subscription edition of MKSAP. Currently available for preorder, you can take advantage of discounted presale pricing and bundles. If you are not already a MKSAP 19 learner, preorder ACP MKSAP today to get immediate, free access to MKSAP 19 Complete Green and its features, including 12 syllabus sections and up to 3,000 associated deep-learning questions.

To learn about ACP MKSAP, please visit our website.

MKSAP 19 Q & A

A 48-year-old woman is evaluated for easy bruising. She has no history of gingival bleeding, menorrhagia, or bleeding following procedures. Medical history is notable only for systemic lupus erythematosus. Medications are prednisone, hydroxychloroquine, and NSAIDs as needed.

On physical examination, vital signs and examination findings are normal.

Laboratory studies show an activated partial thromboplastin time of 38 seconds, platelet count of 190,000/μL (190 × 109/L), and prothrombin time of 12.5 seconds.

Which of the following is the most appropriate diagnostic test?

A: Factor VIII inhibitor titer
B: Factor XI level
C: Factor XII level
D: Mixing study

Answer and Critique

Back to the July 2024 issue of ACP Global